Chronic Myelomonocytic Leukemia (CMML) Terminated Phase 2 Trials for Birinapant (DB11782)

IndicationStatusPhase
DBCOND0037697 (Chronic Myelomonocytic Leukemia (CMML))Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02147873Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoLTreatment